Methods and apparatus for hemostasis following arterial catheterization

Abstract
A method for producing hemostasis of an artery of a patient having a puncture following arterial catheterization including introducing a hemostasis device including at least one electrode into the vicinity of the puncture, supplying an electric current to the at least one electrode, thereby heating blood in the vicinity of the puncture and causing coagulation of the blood and subsequently removing the hemostasis device from the patient.
Description
FIELD OF THE INVENTION

The present invention relates to catheterization systems and methodologies generally and more particularly to post-catheterization closure.


BACKGROUND OF THE INVENTION

Various techniques are known for arterial catheterization. Following arterial catheterization, it is necessary to promote hemostasis quickly and without undue hardship for the patient.


Applicant's U.S. Pat. Nos. 5,728,134 and 6,048,358, and Published PCT Patent Applications WO 98/11830 and WO 00/02488 describe methods and apparatus for hemostasis that greatly simplifies hemostasis and thus greatly reduces patient discomfort following arterial catheterization. These patent documents, the disclosures of which are hereby incorporated by reference, and the prior art referenced therein are considered to represent the state of the art.


SUMMARY OF THE INVENTION

The present invention seeks to provide improved systems and methodologies for post-catheterization closure.


There is thus provided in accordance with a preferred embodiment of the present invention a method for producing hemostasis of an artery of a patient having a puncture following arterial catheterization including introducing a hemostasis device including at least one electrode into the vicinity of the puncture, supplying an electric current to the at least one electrode, thereby heating a volume of blood in the vicinity of the puncture, causing coagulation of the blood and causing closure of the puncture and subsequently removing the hemostasis device from the patient.


In accordance with another preferred embodiment of the present invention the at least one electrode includes a pair of electrodes.


In accordance with yet another preferred embodiment of the present invention the introducing includes introducing via a catheter introducer. Additionally, the introducing also includes inflating an anchor balloon attached to an end of the hemostasis device. Alternatively or additionally, the introducing also includes inflating a peripheral balloon. In accordance with still another preferred embodiment of the present invention the removing the hemostasis device includes deflating the peripheral balloon.


In accordance with another preferred embodiment of the present invention the introducing also includes positioning the at least one electrode in close proximity to the volume of blood.


Preferably, the supplying includes supplying electrical power at RF frequencies. Additionally, the electrical power includes electrical power in the range of 0.1–10 watts at up to 25 volts.


In accordance with yet another preferred embodiment of the present invention the supplying also includes adjusting the electric current based on a feedback measurement.


There is also provided in accordance with another preferred embodiment of the present invention a hemostasis device including a main shaft, at least one balloon and at least one electrode, operable to supply an electric current and to thereby heat a volume of blood adjacent to the at least one electrode and to cause coagulation of the blood and closure of the puncture.


In accordance with another preferred embodiment of the present invention the at least one balloon includes at least one anchor balloon, disposed at an end of the main shaft and at least one peripheral balloon, disposed at a location along the main shaft exterior to a wall of the main shaft. Preferably, the volume of blood is delimited by the peripheral balloon and a wall of the artery.


In accordance with yet another preferred embodiment of the present invention the hemostasis device also includes an electrical power source and control module. Additionally, the electrical power source and control module includes a power supply, operative to supply power to the at least one electrode, feedback measurement means and a processor.


Preferably, the power supply includes an RF power supply which supplies electrical power at RF frequencies within a range of 0.1–10 watts at up to 25 volts.


In accordance with still another preferred embodiment of the present invention the feedback measurement means is operative to measure at least one of electrical current, blood resistance and blood temperature.


Additionally, the processor is operative to adjust the power based on an output from the feedback measurement means.


In accordance with yet another preferred embodiment of the present invention the at least one electrode includes a pair of electrodes.


There is further provided in accordance with yet another preferred embodiment of the present invention a method for producing hemostasis of an artery of a patient having a puncture following arterial catheterization, including introducing a hemostasis device including at least one electrode into the vicinity of the puncture, positioning the at least one electrode in proximity with the puncture, supplying an electric current to the at least one electrode, thereby heating a volume of blood in the vicinity of the puncture, causing coagulation of the blood and causing closure of the puncture and subsequently removing the hemostasis device from the patient.


In accordance with another preferred embodiment of the present invention the positioning includes inflating an anchor balloon attached to an end of the hemostasis device, inflating a peripheral balloon and subsequently deflating the anchor balloon. Preferably, the volume of blood is delimited by the peripheral balloon and a wall of the artery.


In accordance with still another preferred embodiment of the present invention the at least one electrode includes a pair of electrodes.


In accordance with yet another preferred embodiment of the present invention the supplying includes supplying electrical power at RF frequencies. Additionally, the electrical power includes electrical power in the range of 0.1–10 watts at up to 25 volts.


In accordance with another preferred embodiment of the present invention the supplying also includes adjusting the electric power based on a feedback measurement.





BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:



FIG. 1 is a simplified illustration of a hemostasis device constructed and operative in accordance with a preferred embodiment of the present invention;



FIGS. 2A, 2B, 2C, 2D, 2E, 2F, 2G, 2H and 2I are simplified illustrations of the operation of the apparatus of FIG. 1 in a patient treatment context; and



FIG. 3 is a simplified illustration of a hemostasis device constructed and operative in accordance with another preferred embodiment of the present invention.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

Reference is now made to FIG. 1, which is a simplified illustration of a hemostasis device 100 for producing hemostasis following arterial catheterization, in accordance with a preferred embodiment of the present invention. The hemostasis device 100 is suitable for insertion via a conventional catheter introducer (not shown) following completion of catheterization and removal of the catheter from the catheter introducer.


In accordance with a preferred embodiment of the present invention, hemostasis device 100 comprises a main shaft 102, which has an outer wall 104 and preferably includes at least three bores. A first bore, designated generally by reference numeral 110, extends along the main shaft 102 to an anchor balloon inflation location 112. A second bore 120 extends along the shaft 102 to a peripheral balloon inflation location 122. A third bore, designated generally by reference number 130, contains an electrocoagulation heating device 132 connected to an electrical power source and control module 134 by a connector 136.


Disposed at an end of main shaft 102 at anchor balloon inflation location 112 is an anchor balloon 140. Anchor balloon 140 is selectably inflated, as shown in FIG. 2C, via a stopcock 142 and associated conduit 144 in fluid communication with main shaft 102 via a head element 150. Head element 150 is fixed to main shaft 102 at an end thereof opposite the end at which anchor balloon 140 is located. The interior of head element 150 is in fluid communication with first bore 110 in main shaft 102, which in turn is in fluid communication with the interior of the anchor balloon 140 at anchor balloon inflation location 112.


Disposed adjacent the end of second bore 120 in fluid communication with peripheral balloon inflation location 122, exterior of wall 104, is a peripheral balloon 160. Peripheral balloon 160 is selectably inflated, as shown in FIG. 2E, via second bore 120, via a stopcock 162 and associated conduit 164 that communicate with second bore 120 via head element 150.


In accordance with a preferred embodiment of the present invention, electrocoagulation heating device 132 comprises an electrical conductor 170 connected to an electrocoagulation electrode 176 at an extreme end 178 of third bore 130. A pair of electrical cables 180 and 182 extend from electrical power source and control module 134. In the illustrated embodiment, electrical cable 180 serves as a power supply cable and is connected to electrocoagulation heating device 132 by connector 136. Electrical cable 182 serves as a return current cable and is preferably connected to an electrode 184 attached to a body of a patient.


Electrical power source and control module 134 preferably comprises a power supply, preferably an RF power supply source 186, including a feedback measurement circuit 188. The feedback measurement circuit 188 is preferably operative to measure current, blood resistance or blood temperature and thereby determine progress of hemostasis. The electrical power source and control module 134 also preferably includes a microprocessor 190, operative to adjust the power supplied to hemostasis device 100 according to the blood temperature or other feedback measurement received from feedback measurement circuit 188, in order to achieve optimal coagulation of the blood.


In accordance with a preferred embodiment of the present invention an operator actuation switch 192 is connected along electrical cable 180. In accordance with another preferred embodiment, switch 192 may be obviated and electrical cable 180 connected directly to connector 136.


Reference is now made to FIGS. 2A–2I, which illustrate various steps in a preferred mode of operation of the apparatus of FIG. 1.



FIG. 2A illustrates the hemostasis device 100 about to be inserted into an artery 200 via a conventional catheter introducer assembly 202, following completion of a catheterization procedure and withdrawal of a catheter (not shown) from the catheter introducer assembly 202. The catheter introducer assembly 202 conventionally includes a catheter introducer sheath 204.



FIG. 2B shows the hemostasis device 100 inserted into the catheter introducer assembly 202 such that the outer end of the main shaft 102 extends into the artery 200 well beyond the end of catheter introducer sheath 204. As shown with particularity in FIG. 2B, at this stage both anchor balloon 140 and peripheral balloon 160 are deflated.


Reference is now made to FIG. 2C, which shows initial inflation of the anchor balloon 140, preferably by use of a syringe 220 communicating with first bore 110 via the interior of head element 150, stopcock 142 and associated conduit 144. The inflated anchor balloon 140 preferably has a cusp-type configuration as seen with particularity in FIG. 2C.


Following inflation of the anchor balloon 140, the catheter introducer assembly 202 and the hemostasis device 100 are both withdrawn, such that the catheter introducer sheath 204 is removed from artery 200 only when the anchor balloon 140 already engages the interior wall of artery 200 in sealing engagement with the aperture in the artery 200 through which the catheter introducer sheath 204 is drawn and through which the main shaft 102 presently extends. This stage is shown in FIG. 2D.


As seen in FIG. 2E, initial inflation of the peripheral balloon 160 is effected, preferably by use of a syringe 240 communicating with second bore 120 via head element 150, stopcock 162 and associated conduit 164.


Thereafter, as seen in FIG. 2F, the anchor balloon 140 is deflated and the peripheral balloon 160 is more fully inflated, which preferably causes the extreme end of the main shaft 102 to be withdrawn from the artery 200 to a location lying just outside the artery wall. As seen in FIG. 2F, peripheral balloon 160 is preferably designed to allow a limited volume of blood to collect outside of the artery wall after the anchor balloon 140 is deflated. This volume of blood is located in a region, indicated by reference numeral 250, delimited by the engagement of peripheral balloon 160 with the artery wall.


At this stage, electric power is supplied to the electrode 176 to provide heating of the blood in region 250, causing coagulation thereof, as seen in FIG. 2G. In accordance with the illustrated embodiment of FIG. 1 and as shown in FIG. 2G, the electric power is provided by actuation of switch 192. In accordance with another preferred embodiment, switch 192 is obviated, and the electric power is provided by connecting electrical cable 180 (FIG. 1) directly to connector 136.


Preferably, the amount of electrical power supplied along electrical cable 180 (FIG. 1) from electrical power source and control module 134 to the electrocoagulation electrode 176 is between 0.1–10 watts at up to 25 volts at RF frequencies.


Once acceptable hemostasis has occurred in region 250, the peripheral balloon 160 is deflated, as shown in FIG. 2H, preferably by operation of syringe 240 communicating with second bore 120 via head element 150, stopcock 162 and associated conduit 164.


Thereafter, the hemostasis device 100 is entirely withdrawn from the patient, leaving a region 260 of hemostasis outside of artery 200, as shown in FIG. 21.


Reference is now made to FIG. 3, which is a simplified illustration of a hemostasis device constructed and operative in accordance with another preferred embodiment of the present invention. The embodiment of FIG. 3 is similar to that of FIG. 1, except as described hereinbelow. Elements that occur in both embodiments are identified by the same reference numerals.


In the embodiment of FIG. 3, electrocoagulation heating device 132 comprises a pair of separate electrical conductors 300 extending along third bore 130 connecting electrical power source and control module 134 to a pair of electrocoagulation electrodes 302 at end 178 of third bore 130. Electrical cables 180 and 182 are both connected to electrocoagulation heating device 132 by connector 136. The illustrated embodiment shows connector 136 directly connected to electrical cables 180 and 182.


In the embodiment of FIG. 3, the electrodes 302 may be arranged in mutual coaxial arrangement or in mutual side-by-side arrangement or any other suitable arrangement.


It will be appreciated by persons skilled in the art that the present invention is not limited by what has been particularly shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove and shown in the drawings as well as modifications and further developments thereof which would occur to a person of ordinary skill in the art upon reading the foregoing description and which are not in the prior art.

Claims
  • 1. A hemostasis device for closing a puncture in an artery wall, comprising: a main shaft;at least one expandable member disposed on the main shaft, wherein the expandable member in one configuration is adapted to delimit a blood coagulation volume by the engagement of the expandable member against an outside of an artery wall; andat least one electrode, operable to supply an electric current, coupled to the main shaft in the vicinity of the blood coagulation volume, wherein upon activation of the electrode, the electrode is adapted to cause blood disposed in the blood coagulation volume to coagulate thereby causing a closure of the puncture.
  • 2. A hemostasis device according to claim 1 and wherein the at least one expandable member comprises: at least one anchor balloon, disposed at an end of the main shaft; and at least one peripheral balloon, disposed at a location along the main shaft exterior to a wall of the main shaft.
  • 3. A hemostasis device according to claim 2 and wherein the blood coagulation volume is delimited by the peripheral balloon and the artery wall.
  • 4. A hemostasis device according to claim 1 and also comprising an electrical power source and control module connected to the electrode.
  • 5. A hemostasis device according to claim 4 and wherein the electrical power source and control module comprises: a power supply, operative to supply power to the at least one electrode; feedback measurement means for supplying feedback measurements; and a processor.
  • 6. A hemostasis device according to claim 5 and wherein the power supply is an RF power supply.
  • 7. A hemostasis device according to claim 6 and wherein the RF power supply is operative to supply electrical power at RF frequencies within a range of 0.1–10 watts at up to 25 volts.
  • 8. A hemostasis device according to claim 5 and wherein the feedback measurement means is operative to measure at least one of electrical current, blood resistance end blood temperature.
  • 9. A hemostasis device according to claim 5 and wherein the processor is operative to adjust the power based on an output from the feedback measurement means.
  • 10. A hemostasis device according to claim 1 and wherein the at least one electrode is disposed at a distal end of the device.
  • 11. A hemostasis device according to claim 1, where the electrode is disposed at a distal tip of the main shaft.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. application Ser. No. 10/358,130, filed Feb. 4, 2003 now U.S. Pat. No. 7,115,127, titled “METHODS AND APPARATUS FOR HEMOSTASIS FOLLOWING ARTERIAL CATHETERIZATION”, the contents of which are incorporated by reference.

US Referenced Citations (87)
Number Name Date Kind
3595238 Gavrilov et al. Jul 1971 A
3886944 Jamshidi Jun 1975 A
4202337 Hren et al. May 1980 A
4211230 Woltosz Jul 1980 A
4364392 Strother et al. Dec 1982 A
4539987 Nath et al. Sep 1985 A
4744364 Kensey May 1988 A
4836204 Landymore et al. Jun 1989 A
4869248 Narula Sep 1989 A
4929246 Sinofsky May 1990 A
5103804 Abele et al. Apr 1992 A
5122137 Lennox Jun 1992 A
5211624 Cinberg et al. May 1993 A
5217024 Dorsey et al. Jun 1993 A
5342393 Stack Aug 1994 A
5349166 Taylor Sep 1994 A
5370660 Weinstein et al. Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5413571 Katsaros et al. May 1995 A
5415657 Taymor-Luria May 1995 A
5419195 Quinn May 1995 A
5419765 Weldon et al. May 1995 A
5458573 Summers Oct 1995 A
5486195 Myers et al. Jan 1996 A
5507744 Tay et al. Apr 1996 A
5540715 Katsaros et al. Jul 1996 A
5626601 Gershony et al. May 1997 A
5645566 Brenneman et al. Jul 1997 A
5700277 Nash et al. Dec 1997 A
5716375 Fowler Feb 1998 A
5725551 Myers et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728134 Barak Mar 1998 A
5782860 Epstein et al. Jul 1998 A
5810810 Tay et al. Sep 1998 A
5853421 Leschinsky et al. Dec 1998 A
5868778 Gershony et al. Feb 1999 A
5879499 Corvi Mar 1999 A
5891138 Tu et al. Apr 1999 A
5895386 Odell et al. Apr 1999 A
5922009 Epstein et al. Jul 1999 A
5928266 Kontos Jul 1999 A
5941897 Myers Aug 1999 A
6022336 Zadno-Azizi et al. Feb 2000 A
6033398 Farley et al. Mar 2000 A
6033401 Edwards et al. Mar 2000 A
6048358 Barak Apr 2000 A
6056768 Cates et al. May 2000 A
6063085 Tay et al. May 2000 A
6071277 Farley et al. Jun 2000 A
6113598 Baker Sep 2000 A
6126635 Simpson et al. Oct 2000 A
6142994 Swanson et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6179832 Jones et al. Jan 2001 B1
6228082 Baker et al. May 2001 B1
6235027 Herzon May 2001 B1
6322559 Daulton et al. Nov 2001 B1
6352533 Ellman et al. Mar 2002 B1
6398780 Farley et al. Jun 2002 B1
6398782 Pecor et al. Jun 2002 B1
6402745 Wilk Jun 2002 B1
6443947 Marko et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6451007 Koop et al. Sep 2002 B1
6503247 Swartz et al. Jan 2003 B2
6533778 Herzon Mar 2003 B2
6846321 Zucker Jan 2005 B2
7008441 Zucker Mar 2006 B2
7115127 Lindenbaum et al. Oct 2006 B2
20010029373 Baker et al. Oct 2001 A1
20020072761 Abrams et al. Jun 2002 A1
20020156495 Brenneman et al. Oct 2002 A1
20020193808 Belef et al. Dec 2002 A1
20030055397 Zucker Mar 2003 A1
20030093116 Nowakowski May 2003 A1
20030109869 Shadduck Jun 2003 A1
20030120256 Lary et al. Jun 2003 A1
20030125766 Ding Jul 2003 A1
20030153060 Wilson et al. Aug 2003 A1
20030199863 Swanson et al. Oct 2003 A1
20030236518 Marchitto et al. Dec 2003 A1
20040010298 Altshuler et al. Jan 2004 A1
20040092913 Hennings et al. May 2004 A1
20040199155 Mollenauer Oct 2004 A1
20040249342 Khosravi et al. Dec 2004 A1
20060235376 Lindenbaum et al. Oct 2006 A1
Foreign Referenced Citations (17)
Number Date Country
PI0208039 Jan 2006 BR
2514865 Aug 2004 CA
1096884 Aug 2006 DK
1096884 May 2001 EP
1599239 Nov 2005 EP
1711117 Oct 2006 EP
2006-502628 Jan 2006 JP
WO 9811830 Mar 1998 WO
WO-9811830 Mar 1998 WO
WO 0002488 Jan 2000 WO
WO-0002488 Jan 2000 WO
WO 02072188 Sep 2002 WO
WO-02072188 Sep 2002 WO
WO-04069300 Nov 2005 WO
WO-06054170 May 2006 WO
WO-05074364 May 2006 WO
WO-06054170 May 2006 WO
Related Publications (1)
Number Date Country
20040153060 A1 Aug 2004 US
Continuation in Parts (1)
Number Date Country
Parent 10358130 Feb 2003 US
Child 10616887 US